Latest News & Innovations: IBA Dosimetry

IBA reports Half Year 2026 results, on track with its improved profitability trajectory

Louvain-la-Neuve, Belgium, 27 August 2026 - IBA (Ion Beam Applications S.A.), today announces its consolidated results for the first half of 2026, with performance on track with FY…

Mehr als QA: DACH Workshop - Oktober 2026

ECMP 2026: See How IMED Hospital Optimizes QA Workflows in Clinical Practice

Register now to secure your seat!

Meet IBA Dosimetry at 6th ECMP 2026

See us at Booth #18 and learn about our latest innovations for your QA requirements.

myQA SRS for CyberKnife: Patient and Machine QA Experience

Join Nicolas Perichon, Ph.D., Swiss-certified Medical Physicist, as he presents the clinical implementation of the myQA SRS suite for comprehensive patient-specific and machine…

Meet IBA Dosimetry at ASTRO 2026

Discover the latest advances in radiotherapy QA at Booth #843.

Master the Essentials: Commissioning and Small Field Dosimetry

Master the Essentials: Commissioning & Small Field Dosimetry

IBA reports solid Full Year 2024 results

Louvain-la-Neuve, Belgium, 20 March 2025 - IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the…

IBA launches myQA Blue Phantom³ for radiation therapy quality assurance

Fastest automatic levelling offering on the market

Seamless integration with all linear accelerators

IBA launches QUASAR® GRID3D Advantage Image Distortion Analysis System

New standard in the Quality Assurance of image distortion for MR guided radiation therapy and MR simulation in planning